Granules India shares drop nearly 8% after receiving a USFDA warning letter for its Gagillapur facility.

Granules India’s shares dropped nearly 8% after the US FDA issued a warning letter for its Gagillapur facility, citing four concerns. The company assured progress in resolving the issues while continuing product distribution.